Sensyne Health is a clinical artificial intelligence company operating a unique business model. We are a for-profit plc making a positive social impact, sharing the financial returns we make with the NHS and other health systems via equity and a share of revenues.
We supply advanced patient monitoring software to healthcare providers that improve patient outcomes and reduce costs.
We undertake research on behalf of pharmaceutical companies using clinical AI to analyse anonymised patient records to accelerate the development of new medicines.
MagnifEye is an AI-powered software product that transforms any smartphone into an easy-to-use Lateral Flow Test (LFT) reader.Find out more
Our Strategic Research Agreements (SRAs) with healthcare providers allow us access to globally unique, longitudinal anonymised patient datasets.Strategic Research Agreements
Sensyne Health licenses MagnifEye technology to Excalibur Healthcare Services for use with lateral flow diagnostic tests
February 9, 2021
Sensyne Health continues to strengthen its management team with two further senior appointments
February 5, 2021